Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02471287 · ClinicalTrials.gov registry record

Genetics of Inherited Eye Disease

A clinical trial of Genetic Eye Disease, sponsored by National Eye Institute (NEI).

Recruiting
Registry status
1,500
Enrollment target
1
Study location

NCT02471287 is a study of Genetic Eye Disease that is actively recruiting participants, run by National Eye Institute (NEI). The registered enrollment target is 1,500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02471287, a study of Genetic Eye Disease, is actively recruiting participants, sponsored by National Eye Institute (NEI).

RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

Background: Research has identified some of the genes involved in inherited eye diseases. But for many of these diseases, the genes are not yet known. Researchers want to try to find these genes. They also hope to learn more about how symptoms differ in people with similar gene changes. Objective: To learn more about genes involved in eye diseases. Eligibility: People who have a known or suspected inherited eye disease, and their relatives. Design: * All participants will have a medical history, physical exam, and eye exam. They will have blood taken. * Participants with an eye disease may have eye cell samples taken using a swab or biopsy procedure. * Participants may have a skin biopsy. A 3mm piece of skin will be removed. * Participants may provide samples of tears, urine, saliva, stool, hair, or inner cheek cells. * Participants may have a retina test. They may also have a test that uses light to measure retina thickness. * Participants may have an eye movement test. Electrodes will be placed on the skin next to both eyes. * Participants may have a fluorescein angiography. A dye will be given through an intravenous line in the arm. A camera will take pictures of the dye as it flows through the eyes blood vessels. * Participants may have microperimetry. They will sit at a computer screen and press a button when they see a light. * Participants may have an eye movement test. They will wear contact lenses or goggles and watch a series of spots on a computer screen. * Participants may complete a color vision test. * Participants will provide a specimen for genetic testing. * Participants may have a MRI. * Participants may complete questionnaires.

Conditions Studied

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2015-06-22
Est. Completion 2030-09-01

Sponsor

National Eye Institute (NEI)

221 total trials

What the Registry Record Tells You About NCT02471287

The ClinicalTrials.gov registry entry for NCT02471287 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Genetic Eye Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02471287 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02471287 about?

NCT02471287 is a clinical study titled "Genetics of Inherited Eye Disease". Background: Research has identified some of the genes involved in inherited eye diseases. But for many of these diseases, the genes are not yet known. Researchers want to try to find these genes. They also hope to learn more about how symptoms differ in people with similar gene changes. Objective:...

What is the current status of trial NCT02471287?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2015-06-22. Estimated completion is 2030-09-01.

What conditions does trial NCT02471287 study?

This clinical trial studies the following conditions: Genetic Eye Disease.

Who is sponsoring clinical trial NCT02471287?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02471287 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Genetic Eye Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.